
Moving from late to early stage disease: lessons learned from erlotinib in pancreatic cancer
Author(s) -
Andrew H. Ko
Publication year - 2018
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2018.06.02
Subject(s) - medicine , erlotinib , pancreatic cancer , stage (stratigraphy) , disease , adenocarcinoma , pancreatic ductal adenocarcinoma , oncology , cancer , paleontology , epidermal growth factor receptor , biology